Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Expert Opin Ther Pat. 2019 Dec 19;30(1):39–55. doi: 10.1080/13543776.2020.1705783

Figure 9.

Figure 9.

The chemical structures of macrocyclic inhibitors of FXIa (29 and 30) claimed by Sunshine Lake Pharma Co. and Sichuan Kelun-Biotech Biopharmaceutical Co., respectively, from China. Provided are the FXIa IC50 values (nM).